risperidone prolonged‑release injection. It also provides oncology therapies including trifluridine + tipiracil, pegaspargase, nanoliposomal irinotecan as sucrosofate, ivosidenib and vorasidenib. Servier Australia supports healthcare professionals and patients with product information, medical information services and disease education materials. It conducts and supports research and development and enters into agreements with other companies to access and provide novel treatments.